跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
i-Thymus
首页
药物
i-Thymus
i-Thymus
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
NOVEL APIARY COMPOSITION
EP 2148668 A1
申请人: CHEMOR KUTATO FEJLESZTO ES KER
优先权: 2007
EP
WO
2 件公开
METHOD FOR REDUCING OR ELIMINATING ALLOGRAFT REJECTION BY USING THYMUS VACCINE
WO 2025166964 A1
申请人: UNIV TONGJI
优先权: 2024
CN
WO
2 件公开
Use of plant extracts to dye skin according to its phototype
EP 1707191 B1
申请人: BASF BEAUTY CARE SOLUTIONS FRANCE SAS
优先权: 2005
EP
EP 2277502 A3
申请人: BASF BEAUTY CARE SOLUTIONS FRANCE SAS
优先权: 2006
EP
Swine fever oral attenuated freezing-dry vaccine and preparation method thereof and freeze-drying protective agent
CN 106310250 A
申请人: SHANGHAI ACAD AGRI SCIENCES
优先权: 2015
CN
Application of polyethylene glycol artesunate in preparation of anti-pulmonary fibrosis medicine
CN 106492224 A
申请人: KPC PHARMACEUTICALS INC
优先权: 2016
CN
Preparation method of duck natural immune enhancer based on traditional Chinese medicine extract
CN 110613747 A
申请人: ZHEJIANG ACAD AGRICULTURAL SCI
优先权: 2019
CN
Application of epimedium flavonoid glycoside compound in preparation of medicine for treating melanoma
CN 111228287 A
申请人: GOLDEN HEALTH FOSHAN TECH CO LTD
优先权: 2020
CN
Application of BET protein inhibitor in preparation of chronic graft versus host disease medicine
CN 114344467 A
申请人: UNIV SUZHOU
优先权: 2021
CN
GASTROINTESTINAL TABLETS CONSISTING OF A TABLET CORE AND A GASTROINTESTINAL ENVELOPE CONTAINING AT LEAST ONE ACTIVE SUBSTANCE WHICH IS THYMOMODULIN
WO 2025229375 A1
申请人: BIOTARGET SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA
优先权: 2024
WO
Lactobacillus mucilaginosus HFY202414 and application of lactobacillus mucilaginosus HFY202414 in repairing immune impairment
CN 118792203 A
申请人: CHONGQING PAIBAILE BIOTECHNOLOGY CO LTD
优先权: 2024
CN
第 1 / 2 页
上一页
下一页
药物
反馈